Acute Ischemic Stroke Patients clinical trials

Explore recruiting acute ischemic stroke patients clinical trials.

Recruiting acute ischemic stroke patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Ischemic Stroke Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AMASCIS-02. ALOGENIC ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS IN ISCHEMIC STROKE. A PHASE IIB MULTICENTER DOUBLE BLIND PLACEBO CONTROLLED CLINICAL TRIAL.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized placebo-controlled double-blind trial phase II two-arm study to investigate infarct growth over 72 hours assessed with diffusion weighted imaging on MRI after treatment with intravenous tocilizumab or placebo in patients above 18 years of age with acute ischemic stroke undergoing endovascular thrombectomy.

Norway, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

The efficacy and Safety of Intravenous thrombolysis in acute ischemic stroke patients with recent ingestion of Factor Xa-inhibitors Trial (SIFT)

Norway, Denmark, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

MidregiOnal proatrial natriuretic peptide to guide SEcondary Stroke prevention: The MOSES-study. An international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.

Greece, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Ischemic Stroke Patients trials by city

Acute Ischemic Stroke Patients in Toronto Acute Ischemic Stroke Patients in Vancouver Acute Ischemic Stroke Patients in Montreal Acute Ischemic Stroke Patients in Calgary Acute Ischemic Stroke Patients in Edmonton Acute Ischemic Stroke Patients in Ottawa Acute Ischemic Stroke Patients in Winnipeg Acute Ischemic Stroke Patients in Quebec City Acute Ischemic Stroke Patients in Hamilton Acute Ischemic Stroke Patients in Kitchener Acute Ischemic Stroke Patients in London Acute Ischemic Stroke Patients in Halifax Acute Ischemic Stroke Patients in New York Acute Ischemic Stroke Patients in Los Angeles Acute Ischemic Stroke Patients in Chicago Acute Ischemic Stroke Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease